Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3727/215517911X575993 http://scihub22266oqcxt.onion/10.3727/215517911X575993 C4789314!4789314!26998399     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Cell+Med 2011 ; 2 (1): 9-25 Nephropedia Template TP {{tp|p=26998399|t=2011. Management of Liver Failure: From Transplantation to Cell-Based Therapy |pdf=|usr=}}{{26998399}} gab.com Text Management of Liver Failure: From Transplantation to Cell-Based Therapy JO: Cell Med http://www.kidney.de/pget.php?&tw=1&pmid=26998399 #FOAvip The severe shortage of deceased donor organs has driven a search for alternative methods of treating liver failure. In this context, cell-based regenerative medicine is emerging as a promising interdisciplinary field of tissue repair and restoration, able to contribute to improving health in a minimally invasive fashion. Several cell types have allowed long-term survival in experimental models of liver injury, but their therapeutic potential in humans should be regarded with deep caution, because few clinical trials are currently available and the number of patients enrolled so far is too small to assess benefits versus risks. This review summarizes the current literature on the physiological role of endogenous stem cells in liver regeneration and on the therapeutic benefits of exogenous stem cell administration with specific emphasis on the potential clinical uses of mesenchymal stem cells. Moreover, critical points that still need clarification, such as the exact identity of the stem-like cell population exerting the beneficial effects, as well as the limitations of stem cell-based therapies, are discussed. Twit Text FOAVip Management of Liver Failure: From Transplantation to Cell-Based Therapy ????Cell Med http://www.kidney.de/pget.php?&tw=1&pmid=26998399 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26998399 #FOAvip English Wikipedia <ref>{{Cite pmid|26998399}}</ref> Management of Liver Failure: From Transplantation to Cell-Based Therapy #MMPMID26998399 Francipane MG; Cervello M; Vizzini GB; Pietrosi G; Montalto G Cell Med 2011[]; 2 (1): 9-25 PMID26998399show ga The severe shortage of deceased donor organs has driven a search for alternative methods of treating liver failure. In this context, cell-based regenerative medicine is emerging as a promising interdisciplinary field of tissue repair and restoration, able to contribute to improving health in a minimally invasive fashion. Several cell types have allowed long-term survival in experimental models of liver injury, but their therapeutic potential in humans should be regarded with deep caution, because few clinical trials are currently available and the number of patients enrolled so far is too small to assess benefits versus risks. This review summarizes the current literature on the physiological role of endogenous stem cells in liver regeneration and on the therapeutic benefits of exogenous stem cell administration with specific emphasis on the potential clinical uses of mesenchymal stem cells. Moreover, critical points that still need clarification, such as the exact identity of the stem-like cell population exerting the beneficial effects, as well as the limitations of stem cell-based therapies, are discussed. äManagement of Liver Failure: From Transplantation to Cell-Based Therap(epmc).pdf DeepDyve Pubget Overpricing